These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31653892)

  • 21. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
    Joshi AD; Lindström S; Hüsing A; Barrdahl M; VanderWeele TJ; Campa D; Canzian F; Gaudet MM; Figueroa JD; Baglietto L; Berg CD; Buring JE; Chanock SJ; Chirlaque MD; Diver WR; Dossus L; Giles GG; Haiman CA; Hankinson SE; Henderson BE; Hoover RN; Hunter DJ; Isaacs C; Kaaks R; Kolonel LN; Krogh V; Le Marchand L; Lee IM; Lund E; McCarty CA; Overvad K; Peeters PH; Riboli E; Schumacher F; Severi G; Stram DO; Sund M; Thun MJ; Travis RC; Trichopoulos D; Willett WC; Zhang S; Ziegler RG; Kraft P;
    Am J Epidemiol; 2014 Nov; 180(10):1018-27. PubMed ID: 25255808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic architecture of complex traits and disease risk predictors.
    Yong SY; Raben TG; Lello L; Hsu SDH
    Sci Rep; 2020 Jul; 10(1):12055. PubMed ID: 32694572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
    Karunamuni RA; Huynh-Le MP; Fan CC; Thompson W; Eeles RA; Kote-Jarai Z; Muir K; ; Lophatananon A; Tangen CM; Goodman PJ; Thompson IM; Blot WJ; Zheng W; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Park JY; Lin HY; Bensen JT; Fontham ETH; Mohler JL; Taylor JA; Multigner L; Blanchet P; Brureau L; Romana M; Leach RJ; John EM; Fowke J; Bush WS; Aldrich M; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Parent MÉ; Hu JJ; Sanderson M; Mills IG; Andreassen OA; Dale AM; Seibert TM;
    Int J Cancer; 2021 Jan; 148(1):99-105. PubMed ID: 32930425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer.
    Witte JS; Hoffmann TJ
    OMICS; 2011 Jun; 15(6):393-8. PubMed ID: 21348634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method.
    Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G; Bell S; Walsh A; Connor S; Sparrow M; Bowdler LM; Simms LA; Krishnaprasad K; ; Radford-Smith GL; Moser G
    BMC Med Genet; 2017 Aug; 18(1):94. PubMed ID: 28851283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common polygenic variation enhances risk prediction for Alzheimer's disease.
    Escott-Price V; Sims R; Bannister C; Harold D; Vronskaya M; Majounie E; Badarinarayan N; ; ; Morgan K; Passmore P; Holmes C; Powell J; Brayne C; Gill M; Mead S; Goate A; Cruchaga C; Lambert JC; van Duijn C; Maier W; Ramirez A; Holmans P; Jones L; Hardy J; Seshadri S; Schellenberg GD; Amouyel P; Williams J
    Brain; 2015 Dec; 138(Pt 12):3673-84. PubMed ID: 26490334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polygenic risk scores for prediction of breast cancer risk in Asian populations.
    Ho WK; Tai MC; Dennis J; Shu X; Li J; Ho PJ; Millwood IY; Lin K; Jee YH; Lee SH; Mavaddat N; Bolla MK; Wang Q; Michailidou K; Long J; Wijaya EA; Hassan T; Rahmat K; Tan VKM; Tan BKT; Tan SM; Tan EY; Lim SH; Gao YT; Zheng Y; Kang D; Choi JY; Han W; Lee HB; Kubo M; Okada Y; Namba S; ; Park SK; Kim SW; Shen CY; Wu PE; Park B; Muir KR; Lophatananon A; Wu AH; Tseng CC; Matsuo K; Ito H; Kwong A; Chan TL; John EM; Kurian AW; Iwasaki M; Yamaji T; Kweon SS; Aronson KJ; Murphy RA; Koh WP; Khor CC; Yuan JM; Dorajoo R; Walters RG; Chen Z; Li L; Lv J; Jung KJ; Kraft P; Pharoah PDB; Dunning AM; Simard J; Shu XO; Yip CH; Taib NAM; Antoniou AC; Zheng W; Hartman M; Easton DF; Teo SH
    Genet Med; 2022 Mar; 24(3):586-600. PubMed ID: 34906514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing thyroid cancer risk using polygenic risk scores.
    Liyanarachchi S; Gudmundsson J; Ferkingstad E; He H; Jonasson JG; Tragante V; Asselbergs FW; Xu L; Kiemeney LA; Netea-Maier RT; Mayordomo JI; Plantinga TS; Hjartarson H; Hrafnkelsson J; Sturgis EM; Brock P; Nabhan F; Thorleifsson G; Ringel MD; Stefansson K; de la Chapelle A
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5997-6002. PubMed ID: 32132206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing distributions of polygenic risk scores of type 2 diabetes and coronary heart disease within different populations.
    Reisberg S; Iljasenko T; Läll K; Fischer K; Vilo J
    PLoS One; 2017; 12(7):e0179238. PubMed ID: 28678847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
    Lecarpentier J; Silvestri V; Kuchenbaecker KB; Barrowdale D; Dennis J; McGuffog L; Soucy P; Leslie G; Rizzolo P; Navazio AS; Valentini V; Zelli V; Lee A; Amin Al Olama A; Tyrer JP; Southey M; John EM; Conner TA; Goldgar DE; Buys SS; Janavicius R; Steele L; Ding YC; Neuhausen SL; Hansen TVO; Osorio A; Weitzel JN; Toss A; Medici V; Cortesi L; Zanna I; Palli D; Radice P; Manoukian S; Peissel B; Azzollini J; Viel A; Cini G; Damante G; Tommasi S; Peterlongo P; Fostira F; Hamann U; Evans DG; Henderson A; Brewer C; Eccles D; Cook J; Ong KR; Walker L; Side LE; Porteous ME; Davidson R; Hodgson S; Frost D; Adlard J; Izatt L; Eeles R; Ellis S; Tischkowitz M; ; Godwin AK; Meindl A; Gehrig A; Dworniczak B; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Hauke J; Rhiem K; Kast K; Arnold N; Ditsch N; Wang-Gohrke S; Wappenschmidt B; Wand D; Lasset C; Stoppa-Lyonnet D; Belotti M; Damiola F; Barjhoux L; Mazoyer S; ; Van Heetvelde M; Poppe B; De Leeneer K; Claes KBM; de la Hoya M; Garcia-Barberan V; Caldes T; Perez Segura P; Kiiski JI; Aittomäki K; Khan S; Nevanlinna H; van Asperen CJ; ; Vaszko T; Kasler M; Olah E; Balmaña J; Gutiérrez-Enríquez S; Diez O; Teulé A; Izquierdo A; Darder E; Brunet J; Del Valle J; Feliubadalo L; Pujana MA; Lazaro C; Arason A; Agnarsson BA; Johannsson OT; Barkardottir RB; Alducci E; Tognazzo S; Montagna M; Teixeira MR; Pinto P; Spurdle AB; Holland H; ; Lee JW; Lee MH; Lee J; Kim SW; Kang E; Kim Z; Sharma P; Rebbeck TR; Vijai J; Robson M; Lincoln A; Musinsky J; Gaddam P; Tan YY; Berger A; Singer CF; Loud JT; Greene MH; Mulligan AM; Glendon G; Andrulis IL; Toland AE; Senter L; Bojesen A; Nielsen HR; Skytte AB; Sunde L; Jensen UB; Pedersen IS; Krogh L; Kruse TA; Caligo MA; Yoon SY; Teo SH; von Wachenfeldt A; Huo D; Nielsen SM; Olopade OI; Nathanson KL; Domchek SM; Lorenchick C; Jankowitz RC; Campbell I; James P; Mitchell G; Orr N; Park SK; Thomassen M; Offit K; Couch FJ; Simard J; Easton DF; Chenevix-Trench G; Schmutzler RK; Antoniou AC; Ottini L
    J Clin Oncol; 2017 Jul; 35(20):2240-2250. PubMed ID: 28448241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations.
    Wang Y; Guo J; Ni G; Yang J; Visscher PM; Yengo L
    Nat Commun; 2020 Jul; 11(1):3865. PubMed ID: 32737319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk.
    Jermy B; Läll K; Wolford BN; Wang Y; Zguro K; Cheng Y; Kanai M; Kanoni S; Yang Z; Hartonen T; Monti R; Wanner J; Youssef O; ; ; Lippert C; van Heel D; Okada Y; McCartney DL; Hayward C; Marioni RE; Furini S; Renieri A; Martin AR; Neale BM; Hveem K; Mägi R; Palotie A; Heyne H; Mars N; Ganna A; Ripatti S
    Nat Commun; 2024 Jun; 15(1):5007. PubMed ID: 38866767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model.
    Li H; Yang L; Zhao X; Wang J; Qian J; Chen H; Fan W; Liu H; Jin L; Wang W; Lu D
    BMC Med Genet; 2012 Dec; 13():118. PubMed ID: 23228068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores.
    Isgut M; Giuste F; Gloster L; Swain A; Choi K; Hornback A; Deshpande SR; Wang MD
    Sci Rep; 2024 Sep; 14(1):22124. PubMed ID: 39333190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating polygenic risk into the Leicester Risk Assessment score for 10-year risk prediction of type 2 diabetes.
    Liu X; Littlejohns TJ; Bešević J; Bragg F; Clifton L; Collister JA; Trichia E; Gray LJ; Khunti K; Hunter DJ
    Diabetes Metab Syndr; 2024 Apr; 18(4):102996. PubMed ID: 38608567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts.
    Steinberg J; Iles MM; Lee JY; Wang X; Law MH; Smit AK; Nguyen-Dumont T; Giles GG; Southey MC; Milne RL; Mann GJ; Bishop DT; MacInnis RJ; Cust AE
    Br J Dermatol; 2022 May; 186(5):823-834. PubMed ID: 34921685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities.
    Mittag F; Büchel F; Saad M; Jahn A; Schulte C; Bochdanovits Z; Simón-Sánchez J; Nalls MA; Keller M; Hernandez DG; Gibbs JR; Lesage S; Brice A; Heutink P; Martinez M; Wood NW; Hardy J; Singleton AB; Zell A; Gasser T; Sharma M;
    Hum Mutat; 2012 Dec; 33(12):1708-18. PubMed ID: 22777693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes.
    Tam CH; Ho JS; Wang Y; Lam VK; Lee HM; Jiang G; Lau ES; Kong AP; Fan X; Woo JL; Tsui SK; Ng MC; So WY; Chan JC; Ma RC
    PLoS One; 2013; 8(12):e83093. PubMed ID: 24376643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiethnic polygenic risk scores improve risk prediction in diverse populations.
    Márquez-Luna C; Loh PR; ; ; Price AL
    Genet Epidemiol; 2017 Dec; 41(8):811-823. PubMed ID: 29110330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.
    Pierce BL; Ahsan H
    Hum Hered; 2010; 69(3):193-201. PubMed ID: 20203524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.